Death receptor 5 agonist TRA8 in combination with the bisphosphonate zoledronic acid attenuated the growth of breast cancer metastasis.
about
Variants of Osteoprotegerin Lacking TRAIL Binding for Therapeutic Bone Remodeling in Osteolytic Malignancies.In vivo imaging in cancer.Breast cancer proteome takes more than two to tango on TRAIL: beat them at their own game.Multispectral imaging: a review of its technical aspects and applications in anatomic pathology.
P2860
Death receptor 5 agonist TRA8 in combination with the bisphosphonate zoledronic acid attenuated the growth of breast cancer metastasis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Death receptor 5 agonist TRA8 ...... h of breast cancer metastasis.
@ast
Death receptor 5 agonist TRA8 ...... h of breast cancer metastasis.
@en
type
label
Death receptor 5 agonist TRA8 ...... h of breast cancer metastasis.
@ast
Death receptor 5 agonist TRA8 ...... h of breast cancer metastasis.
@en
prefLabel
Death receptor 5 agonist TRA8 ...... h of breast cancer metastasis.
@ast
Death receptor 5 agonist TRA8 ...... h of breast cancer metastasis.
@en
P2093
P2860
P356
P1476
Death receptor 5 agonist TRA8 ...... h of breast cancer metastasis.
@en
P2093
April Adams Szafran
Diptiman Chanda
Jason Warram
Karri Folks
Kurt R Zinn
P2860
P304
P356
10.4161/CBT.8.12.8327
P577
2009-06-01T00:00:00Z